The Scripps NeuroAIDS Preclinical Studies (SNAPS) Center has been organized in order to allow the continuation and expansion of an innovative cross-disciplinary program of research at The Scripps Research Institute (TSRI) focusing on modeling untoward effects of HIV on the central nervous system (CNS). The spirit of the proposed CSPAR is to build on this history and continue to recruit from among the outstanding investigators in many aspects of basic immune and nervous system function whose research and expertise, if applied to the problems occurring in NeuroAIDS, could significantly improve our understanding of this condition. The overall goal of the Development Core is to award grants that will serve the purpose of stimulating new insights into the CNS damaged induced by HIV infection. Awards will take the form of small grants (approximately $40,000 direct costs per year), not to exceed two years total duration. It is expected that this initial funding will provide an opportunity to generate preliminary findings to support future application for NIH grant funds. Three major categories of applications will be considered for funding by the Core: 1) New investigators seeks to establish research programs in the area of NeuroAIDS, 2) Established investigators of diverse background that have no track record in NeuroAIDS and 3) Researchers established in NeuroAIDS, but proposing research that represents a significant departure from previous work. Applications will be evaluated by a panel, headed by the Core PI, comprised of members from both inside and outside TSRI. Criteria for selection for funding will include the overall scientific merit of the proposed work; the relevance to NeuroAIDS and fulfillment of the CSPAR aim to stimulate inter- and multi-disciplinary collaborations for research on the mental health issues of HIV infection; and the likelihood for success given the credentials of the investigator and the specific research environment. TSRI is uniquely suited to bring together scientists of diverse experience and background to carry out innovative research relevant to NeuroAIDS. As such, the potential is high for generating new ideas and fresh approaches to understanding mechanisms of lentivirus invasion of the CNS as well as to develop intervention strategies and therapeutic approaches to block, limit, and/or control infection of the CNS.

Agency
National Institute of Health (NIH)
Institute
National Institute of Mental Health (NIMH)
Type
Center Core Grants (P30)
Project #
5P30MH062261-02
Application #
6504179
Study Section
Special Emphasis Panel (ZMH1)
Project Start
2001-09-01
Project End
2002-08-31
Budget Start
Budget End
Support Year
2
Fiscal Year
2001
Total Cost
Indirect Cost
Name
Scripps Research Institute
Department
Type
DUNS #
City
La Jolla
State
CA
Country
United States
Zip Code
92037
Olson, Katherine E; Bade, Aditya N; Namminga, Krista L et al. (2018) Persistent EcoHIV infection induces nigral degeneration in 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-intoxicated mice. J Neurovirol 24:398-410
Hu, Guoku; Liao, Ke; Niu, Fang et al. (2018) Astrocyte EV-Induced lincRNA-Cox2 Regulates Microglial Phagocytosis: Implications for Morphine-Mediated Neurodegeneration. Mol Ther Nucleic Acids 13:450-463
Schutt, Charles R; Gendelman, Howard E; Mosley, R Lee (2018) Tolerogenic bone marrow-derived dendritic cells induce neuroprotective regulatory T cells in a model of Parkinson's disease. Mol Neurodegener 13:26
Sillman, Brady; Bade, Aditya N; Dash, Prasanta K et al. (2018) Creation of a long-acting nanoformulated dolutegravir. Nat Commun 9:443
Domingo-Almenara, Xavier; Montenegro-Burke, J Rafael; Benton, H Paul et al. (2018) Annotation: A Computational Solution for Streamlining Metabolomics Analysis. Anal Chem 90:480-489
Thomas, Midhun B; Gnanadhas, Divya Prakash; Dash, Prasanta K et al. (2018) Modulating cellular autophagy for controlled antiretroviral drug release. Nanomedicine (Lond) 13:2139-2154
Spooner, Rachel K; Wiesman, Alex I; Mills, Mackenzie S et al. (2018) Aberrant oscillatory dynamics during somatosensory processing in HIV-infected adults. Neuroimage Clin 20:85-91
Kiyota, Tomomi; Machhi, Jatin; Lu, Yaman et al. (2018) URMC-099 facilitates amyloid-? clearance in a murine model of Alzheimer's disease. J Neuroinflammation 15:137
Guijas, Carlos; Montenegro-Burke, J Rafael; Warth, Benedikt et al. (2018) Metabolomics activity screening for identifying metabolites that modulate phenotype. Nat Biotechnol 36:316-320
Kevadiya, Bhavesh D; Woldstad, Christopher; Ottemann, Brendan M et al. (2018) Multimodal Theranostic Nanoformulations Permit Magnetic Resonance Bioimaging of Antiretroviral Drug Particle Tissue-Cell Biodistribution. Theranostics 8:256-276

Showing the most recent 10 out of 374 publications